NS 2028
CAS: 204326-43-2
Ref. 3D-EIA32643
| 1mg | Descatalogado | ||
| 5mg | Descatalogado | ||
| 10mg | Descatalogado | ||
| 25mg | Descatalogado | ||
| 50mg | Descatalogado |
Información del producto
Nombre:
NS 2028
Sinónimos:
- 1H,4H-[1,2,4]Oxadiazolo[3,4-c][1,4]benzoxazin-1-one, 8-bromo-
- 4H-8-Bromo-1,2,4-oxadiazolo(3,4-d)ben(b)(1,4)oxazin-1-one
- 8-Bromo-1H,4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one
- Ns 2028
- 8-Bromo-4H-[1,2,4]oxadiazolo[3,4-c][1,4]benzoxazin-1-one
Descripción:
NS 2028 is an inhibitor of cyclase, a signal transduction protein that is responsible for the conversion of inactive GTP to active cGMP. NS 2028 inhibits the production of cGMP by binding to and blocking the active site on cyclase, which prevents the phosphorylation and activation of downstream cellular proteins. NS 2028 has been shown to inhibit the light-induced oxidative stress response in a human prostate cancer cell line (Du-145) by reducing intracellular calcium levels and inhibiting signal pathways that lead to mitochondrial membrane potential disruption.
Aviso:
Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Marca:
Biosynth
Almacenamiento de larga duración:
Notas:
Propiedades químicas
Peso molecular:
269.05 g/mol
Fórmula:
C9H5BrN2O3
Pureza:
Min. 95%
MDL:
Punto de fusión:
Punto de ebullición:
Punto de inflamabilidad:
Densidad:
Concentración:
EINECS:
Merck:
Código HS:
